Viatris Inc. (VIA.DE)
| Previous close | 10.10 |
| Open | 10.13 |
| Bid | 10.09 x N/A |
| Ask | 10.22 x N/A |
| Day's range | 10.10 - 10.16 |
| 52-week range | 8.28 - 12.60 |
| Volume | |
| Avg. volume | 2,574 |
| Market cap | 12.02B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.45 (4.42%) |
| Ex-dividend date | 23 May 2024 |
| 1y target est | N/A |
- PR Newswire
Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today published its 2023 Sustainability Report: Building Sustainable Access at Scale. The report highlights its actions and initiatives across multiple areas of focus in support of the Company's efforts to continue to be a model for sustainable access to medicine and to make a difference in the communities it serves.
- PR Newswire
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
Reports Total Revenues of $3.66 Billion; U.S. GAAP Net Earnings of $113.9 Million; Adjusted EBITDA of $1.19 Billion; U.S. GAAP EPS of $0.09; Adjusted EPS of $0.67; U.S. GAAP Net Cash Provided by Operating Activities of $615 Million; and Free Cash Flow of $565 Million for the First Quarter
- PR Newswire
Viatris to Participate in the BofA Securities 2024 Health Care Conference
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada on Tuesday, May 14, 2024. Chief Financial Officer Doretta Mistras and Chief R&D Officer Philippe Martin will represent the company in a fireside chat scheduled at 10 a.m. PT / 1 p.m. ET.
